...
rnxt-img

RenovoRx Inc, Common Stock

RNXT

NAQ

$1.41

+$0.04

(2.92%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$34.32M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
226.69K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.99
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.68 L
$2.35 H
$1.41

About RenovoRx Inc, Common Stock

RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is RenovoGem, an oncology drug-device combination product, consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameRNXTSectorS&P500
1-Week Return18.49%-1.8%-0.77%
1-Month Return21.55%-3.48%0.71%
3-Month Return34.21%-7.2%8.81%
6-Month Return34.29%-1.54%12.32%
1-Year Return120.31%8.39%30.57%
3-Year Return-75.65%6.07%29.21%
5-Year Return-80.58%44.07%91.95%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue--9.00K6.00K-[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":66.67,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit--(9.00K)(6.00K)-[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-900000,"profit":false},{"date":"2022-12-31","value":-600000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses3.90M3.20M5.67M9.95M11.40M[{"date":"2019-12-31","value":34.19,"profit":true},{"date":"2020-12-31","value":28.12,"profit":true},{"date":"2021-12-31","value":49.76,"profit":true},{"date":"2022-12-31","value":87.31,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(3.90M)(3.20M)(5.67M)(9.95M)(11.40M)[{"date":"2019-12-31","value":-389600000,"profit":false},{"date":"2020-12-31","value":-320400000,"profit":false},{"date":"2021-12-31","value":-567100000,"profit":false},{"date":"2022-12-31","value":-995000000,"profit":false},{"date":"2023-12-31","value":-1139600000,"profit":false}]
Total Non-Operating Income/Expense120.00K(1.18M)(1.49M)118.00K1.27M[{"date":"2019-12-31","value":9.41,"profit":true},{"date":"2020-12-31","value":-92.63,"profit":false},{"date":"2021-12-31","value":-116.63,"profit":false},{"date":"2022-12-31","value":9.25,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(3.84M)(3.80M)(6.32M)(9.89M)(10.23M)[{"date":"2019-12-31","value":-383900000,"profit":false},{"date":"2020-12-31","value":-379800000,"profit":false},{"date":"2021-12-31","value":-632400000,"profit":false},{"date":"2022-12-31","value":-988900000,"profit":false},{"date":"2023-12-31","value":-1023200000,"profit":false}]
Income Taxes(63.00K)587.00K772.00K(118.00K)(6.00)[{"date":"2019-12-31","value":-8.16,"profit":false},{"date":"2020-12-31","value":76.04,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-15.28,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(3.78M)(4.38M)(7.10M)(9.77M)(10.23M)[{"date":"2019-12-31","value":-377600000,"profit":false},{"date":"2020-12-31","value":-438500000,"profit":false},{"date":"2021-12-31","value":-709600000,"profit":false},{"date":"2022-12-31","value":-977100000,"profit":false},{"date":"2023-12-31","value":-1023199400,"profit":false}]
Income From Continuous Operations(3.84M)(3.80M)(6.32M)(9.89M)(9.16M)[{"date":"2019-12-31","value":-383900000,"profit":false},{"date":"2020-12-31","value":-379800000,"profit":false},{"date":"2021-12-31","value":-632400000,"profit":false},{"date":"2022-12-31","value":-988900000,"profit":false},{"date":"2023-12-31","value":-916100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(3.78M)(4.38M)(7.10M)(9.77M)(10.23M)[{"date":"2019-12-31","value":-377600000,"profit":false},{"date":"2020-12-31","value":-438500000,"profit":false},{"date":"2021-12-31","value":-709600000,"profit":false},{"date":"2022-12-31","value":-977100000,"profit":false},{"date":"2023-12-31","value":-1023200000,"profit":false}]
EPS (Diluted)(0.48)(0.86)(1.44)(1.09)(1.11)[{"date":"2019-12-31","value":-47.88,"profit":false},{"date":"2020-12-31","value":-86.05,"profit":false},{"date":"2021-12-31","value":-144.33,"profit":false},{"date":"2022-12-31","value":-109,"profit":false},{"date":"2023-12-31","value":-111,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

RNXT
Cash Ratio 5.40
Current Ratio 5.66

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

RNXT
ROA (LTM) -70.08%
ROE (LTM) -155.12%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

RNXT
Debt Ratio Lower is generally better. Negative is bad. 0.30
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.70

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

RNXT
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 4.65
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is RenovoRx Inc share price today?

RenovoRx Inc (RNXT) share price today is $1.41

Can Indians buy RenovoRx Inc shares?

Yes, Indians can buy shares of RenovoRx Inc (RNXT) on Vested. To buy RenovoRx Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RNXT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of RenovoRx Inc be purchased?

Yes, you can purchase fractional shares of RenovoRx Inc (RNXT) via the Vested app. You can start investing in RenovoRx Inc (RNXT) with a minimum investment of $1.

How to invest in RenovoRx Inc shares from India?

You can invest in shares of RenovoRx Inc (RNXT) via Vested in three simple steps:

  • Click on Sign Up or Invest in RNXT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in RenovoRx Inc shares
What is RenovoRx Inc 52-week high and low stock price?

The 52-week high price of RenovoRx Inc (RNXT) is $2.35. The 52-week low price of RenovoRx Inc (RNXT) is $0.68.

What is RenovoRx Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of RenovoRx Inc (RNXT) is

What is RenovoRx Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of RenovoRx Inc (RNXT) is 4.65

What is RenovoRx Inc dividend yield?

The dividend yield of RenovoRx Inc (RNXT) is 0.00%

What is the Market Cap of RenovoRx Inc?

The market capitalization of RenovoRx Inc (RNXT) is $34.32M

What is RenovoRx Inc’s stock symbol?

The stock symbol (or ticker) of RenovoRx Inc is RNXT

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top